News

SOM BIOTECH LICENSES ITS FIRST DRUG

Posted on by admin

SOM has licensed to the biotech  ARGON Pharma  a new product with potential properties for the treatment of multiforme glioblastoma. The compound was discovered by SOM as SOM0777.

SUBCRIBE TO OUR NEWSLETTER

    Name*
    Email*


    I confirm that by completing this form I have used only personal data about myself and that they are true and up-to-date.
    SOM INNOVATION BIOTECH, S.A. is responsible for the processing of my personal data to manage the newsletter service requested through the form, as well as to track the receipt of these through tracking technologies. The Privacy Policy tells me how I can exercise my rights of access, rectification, deletion, limitation, portability and opposition.